Clinical Trial Update: Etonogestrel Implants Protect Ovarian Reserve Function in Systemic Lupus Erythematosus [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update indicates etonogestrel implants are being studied for preserving ovarian reserve in systemic lupus erythematosus, spanning Phase 2 and P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Etonogestrel implant (etonogestrel)

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Systemic Lupus Erythematosus | Phase 2, Phase 3 | Status: UNKNOWN